Enzo Biochem Inc. (ENZ) Sets New 52-Week High at $7.00
Enzo Biochem Inc. (NYSE:ENZ)’s share price hit a new 52-week high during mid-day trading on Friday . The stock traded as high as $7.00 and last traded at $6.94, with a volume of 246,252 shares changing hands. The stock had previously closed at $6.70.
Separately, Zacks Investment Research raised shares of Enzo Biochem from a “sell” rating to a “hold” rating in a research note on Tuesday, May 24th.
The firm has a 50-day moving average price of $6.08 and a 200-day moving average price of $5.21. The company has a market cap of $322.46 million and a P/E ratio of 18.25.
Enzo Biochem (NYSE:ENZ) last released its quarterly earnings results on Wednesday, June 8th. The company reported ($0.04) EPS for the quarter, topping analysts’ consensus estimates of ($0.06) by $0.02. The company had revenue of $18.16 million for the quarter, compared to the consensus estimate of $24.50 million. During the same quarter last year, the firm posted ($0.07) earnings per share. On average, analysts expect that Enzo Biochem Inc. will post ($0.23) EPS for the current year.
Enzo Biochem, Inc (Enzo) is an integrated life science and biotechnology company, which is engaged in the research, development, manufacturing and marketing of diagnostic and research products based on genetic engineering, biotechnology and molecular biology. These products are designed for the diagnosis of and/or screening for infectious diseases, cancers, genetic defects and other medically pertinent diagnostic information and are distributed in the United States and internationally.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.